Neurology devices Market by Product (Neurostimulation Devices, Neurosurgery Device, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices, and Others) and End User (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics): Global Opportunity Analysis and Industry Forecast, 2019–2026

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Research methodology

1.3.1. Secondary research

1.3.2. Primary research

1.3.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Moderate bargaining power of buyers

3.3.2. Low bargaining power of suppliers

3.3.3. Moderate threat of substitutes

3.3.4. Low threat of new entrants

3.3.5. Moderate competitive rivalry

3.4. Top player positioning

3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Surge in neurological disorders

3.5.1.2. Rising demand for noninvasive diagnostic techniques for neurological disorders

3.5.2. Restraint

3.5.2.1. Implementation of stringent government regulations towards approval of neurology devices

3.5.3. Opportunity

3.5.3.1. Various growth opportunities in emerging economies

CHAPTER 4: NEUROLOGY DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Neurostimulation devices

4.2.1. Key market trends and opportunities

4.2.2. Market size and forecast

4.2.3. Market share analysis, by country

4.3. Neurosurgery device

4.3.1. Key market trends and growth opportunities

4.3.2. Market size and forecast

4.3.3. Market share analysis, by country

4.4. Interventional neurology devices

4.4.1. Key market trends and opportunities

4.4.2. Market size and forecast

4.4.3. Market share analysis, by country

4.5. Cerebrospinal fluid management devices

4.5.1. Key market trends and opportunities

4.5.2. Market size and forecast

4.5.3. Market share analysis, by country

4.6. Others

4.6.1. Key market trends and opportunities

4.6.2. Market size and forecast

4.6.3. Market share analysis, by country

CHAPTER 5: NEUROLOGY DEVICES MARKET, BY END USER

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Market size and forecast

5.2.2. Market share analysis, by country

5.3. Ambulatory surgery centers

5.3.1. Market size and forecast

5.3.2. Market share analysis, by country

5.4. Neurology clinics

5.4.1. Market size and forecast

5.4.2. Market share analysis, by country

CHAPTER 6: NEUROLOGY DEVICES MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities

6.2.2. Market size and forecast, by country

6.2.3. Market size and forecast, by product

6.2.4. Market size and forecast, by end user

6.2.4.1. U.S. market size and forecast, by product

6.2.4.2. U.S. market size and forecast, by end user

6.2.4.3. Canada market size and forecast, by product

6.2.4.4. Canada market size and forecast, by end user

6.2.4.5. Mexico market size and forecast, by product

6.2.4.6. Mexico market size and forecast, by end user

6.3. Europe

6.3.1. Key growth factors and opportunities

6.3.2. Market size and forecast, by country

6.3.3. Market size and forecast, by product

6.3.4. Market size and forecast, by product

6.3.4.1. Germany market size and forecast, by product

6.3.4.2. Germany market size and forecast, by end user

6.3.4.3. France market size and forecast, by product

6.3.4.4. France market size and forecast, by end user

6.3.4.5. UK market size and forecast, by end user

6.3.4.6. UK market size and forecast, by end user

6.3.4.7. Italy market size and forecast, by product

6.3.4.8. Italy market size and forecast, by end user

6.3.4.10. Rest of Europe market size and forecast, by product

6.3.4.11. Rest of Europe market size and forecast, by end user

6.4. Asia-Pacific

6.4.1. Key growth factors and opportunities.

6.4.2. Market size and forecast, by country

6.4.3. Market size and forecast, by product

6.4.4. Market size and forecast, by end user

6.4.4.1. Japan market size and forecast, by end user

6.4.4.2. Japan market size and forecast, by end user

6.4.4.3. China market size and forecast, by product

6.4.4.4. China market size and forecast, by end user

6.4.4.5. India market size and forecast, by product

6.4.4.6. India market size and forecast, by end user

6.4.4.7. Rest of Asia-Pacific market size and forecast, by product

6.4.4.8. Rest of Asia-Pacific market size and forecast, by end user

6.5. LAMEA

6.5.1. Key growth factors and opportunities

6.5.2. Market size and forecast, by country

6.5.3. Market size and forecast, by product

6.5.4. Market size and forecast, by end user

6.5.4.1. Brazil market size and forecast, by end user

6.5.4.2. Brazil market size and forecast, by end user

6.5.4.3. Saudi Arabia market size and forecast, by product

6.5.4.4. Saudi Arabia market size and forecast, by end user

6.5.5.1. South Africa market size and forecast, by product

6.5.5.2. South Africa market size and forecast, by end user

6.5.5.3. Rest of LAMEA market size and forecast, by product

6.5.5.4. Rest of LAMEA market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES

7.1. Abbott Laboratories

7.1.1. Company overview

7.1.2. Company snapshot

7.1.3. Operating business segments

7.1.4. Product portfolio

7.1.5. Business performance

7.2. B. BRAUN MELSUNGEN AG

7.2.1. Company overview

7.2.2. Company snapshot

7.2.3. Operating business segments

7.2.4. Product Portfolio

7.2.5. Business performance

7.3. Boston Scientific Corporation

7.3.1. Company overview

7.3.2. Company snapshot

7.3.3. Operating business segments

7.3.4. Product portfolio

7.3.5. Business performance

7.3.6. Key strategic moves and developments

7.4. Integra LifeSciences Holdings Corporation

7.4.1. Company overview

7.4.2. Company snapshot

7.4.3. Operating business segments

7.4.4. Product portfolio

7.4.5. Business performance

7.4.6. Key strategic moves and developments

7.5. Johnson & Johnson

7.5.1. Company overview

7.5.2. Company snapshot

7.5.3. Operating business segments

7.5.4. Product portfolio

7.5.5. Business performance

7.6. LivaNova PLC

7.6.1. Company overview

7.6.2. Company snapshot

7.6.3. Operating business segments

7.6.4. Product portfolio

7.6.5. Business performance

7.6.6. Key strategic moves and developments

7.7. Medtronic Plc

7.7.1. Company overview

7.7.2. Company snapshot

7.7.3. Operating business segments

7.7.4. Product portfolio

7.7.5. Business performance

7.7.6. Key strategic moves and developments

7.8. Magstim Co Ltd.

7.8.1. Company overview

7.8.2. Operating business segments

7.8.3. Product portfolio

7.8.4. Key strategic moves and developments

7.9. Penumbra, Inc.

7.9.1. Company overview

7.9.2. Company snapshot

7.9.3. Operating business segments

7.9.4. Product portfolio

7.9.5. Business performance

7.10. Stryker Corporation

7.10.1. Company overview

7.10.2. Company snapshot

7.10.3. Operating business segments

7.10.4. Product portfolio

7.10.5. Business performance

TABLE 01. NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 02. NEUROSTIMULATION DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)

TABLE 03. NEUROSURGERY DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)

TABLE 04. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)

TABLE 05. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)

TABLE 06. OTHER DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)

TABLE 07. NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 08. NEUROLOGY DEVICES MARKET FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)

TABLE 09. NEUROLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2018–2026 ($MILLION)

TABLE 10. NEUROLOGY DEVICES MARKET FOR NEUROLOGY CLINICS, BY REGION, 2018–2026 ($MILLION)

TABLE 11. GLOBAL NEUROLOGY DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)

TABLE 12. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 13. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 14. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION),

TABLE 15. U.S. NEUROLOGY DEVICES MARKET BY PRODUCT, 2018–2026 ($MILLION)

TABLE 16. U.S. NEUROLOGY DEVICES MARKET BY END USER, 2018–2026 ($MILLION)

TABLE 17. CANADA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 18. CANADA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 19. MEXICO NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 20. MEXICO NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 21. EUROPE NEUROLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 22. EUROPE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 23. EUROPE NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION),

TABLE 24. GERMANY NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 25. GERMANY NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 26. FRANCE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 27. FRANCE NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 28. U.K. NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 29. U.K. NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 30. ITALY NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 31. ITALY NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 32. REST OF EUROPE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 33. REST OF EUROPE NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 34. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 35. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 36. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION),

TABLE 37. JAPAN NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 38. JAPAN NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 39. CHINA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 40. CHINA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 41. INDIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 42. INDIA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 43. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 44. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 45. LAMEA NEUROLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 46. LAMEA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 47. LAMEA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION),

TABLE 48. BRAZIL NEUROLOGY DEVICES MARKET, BY PRODUCT 2018–2026 ($MILLION)

TABLE 49. BRAZIL NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 50. SAUDI ARABIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 51. SAUDI ARABIA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 52. SOUTH AFRICA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 53. SOUTH AFRICA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 54. REST OF LAMEA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)

TABLE 55. REST OF LAMEA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 56. ABBOTT: COMPANY SNAPSHOT

TABLE 57. ABBOTT: OPERATING SEGMENTS

TABLE 58. ABBOTT: PRODUCT PORTFOLIO

TABLE 59. B. BRAUN: COMPANY SNAPSHOT

TABLE 60. B. BRAUN: OPERATING SEGMENTS

TABLE 61. B. BRAUN: PRODUCT PORTFOLIO

TABLE 62. BOSTON SCIENTIFIC: COMPANY SNAPSHOT

TABLE 63. BOSTON SCIENTIFIC: OPERATING SEGMENTS

TABLE 64. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO

TABLE 65. INTEGRA: COMPANY SNAPSHOT

TABLE 66. INTEGRA: OPERATING SEGMENTS

TABLE 67. INTEGRA: PRODUCT PORTFOLIO

TABLE 68. JOHNSON & JOHNSON: COMPANY SNAPSHOT

TABLE 69. J&J: OPERATING SEGMENT

TABLE 70. J&J.: PRODUCT PORTFOLIO

TABLE 71. LIVANOVA: COMPANY SNAPSHOT

TABLE 72. LIVANOVA: OPERATING SEGMENT

TABLE 73. LIVANOVA: PRODUCT PORTFOLIO

TABLE 74. MEDTRONIC: COMPANY SNAPSHOT

TABLE 75. MEDTRONIC: OPERATING SEGMENTS

TABLE 76. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 77. MAGSTIM: OPERATING SEGMENT

TABLE 78. MAGSTIM: PRODUCT PORTFOLIO

TABLE 79. PENUMBRA.: COMPANY SNAPSHOT

TABLE 80. PENUMBRA.: OPERATING SEGMENTS

TABLE 81. PENUMBRA.: PRODUCT PORTFOLIO

TABLE 82. STRYKER: COMPANY SNAPSHOT

TABLE 83. STRYKER: OPERATING SEGMENTS

TABLE 84. STRYKER: PRODUCT PORTFOLIO